The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

 

Neogen Corp

Nasdaq: NEOG
Last

(U.S.) $49.01

Today's change+0.80 +1.66%
Updated December 26 4:00 PM EST. Delayed by at least 15 minutes.
 

Neogen Corp

Nasdaq: NEOG
Last

(U.S.) $49.01

Today's change+0.80 +1.66%
Updated December 26 4:00 PM EST. Delayed by at least 15 minutes.

Neogen Corp up sharply

Neogen Corp closed up sharply Friday, rallying (U.S.)$0.80 or 1.66% to (U.S.)$49.01. Over the last five days, shares have gained 1.51% and are currently 3.56% off of the 52-week high. Shares have underperformed the S&P 500 by 7.36% during the last year.

Key company metrics

  • Open(U.S.) $48.52
  • Previous close(U.S.) $48.21
  • High(U.S.) $49.47
  • Low(U.S.) $48.42
  • Bid / Ask-- / --
  • YTD % change+7.24%
  • Volume130,806
  • Average volume (10-day)254,405
  • Average volume (1-month)193,978
  • Average volume (3-month)152,110
  • 52-week range(U.S.) $35.50 to (U.S.) $50.82
  • Beta1.06
  • Trailing P/E59.48×
  • P/E 1 year forward52.63×
  • Forward PEG3.47×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $0.82
Updated December 26 4:00 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+11.62%

Based on its net profit margin of 11.62%, Neogen Corp is less effective than other companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.10%Sector:HealthcareIndustry:Medical Equipment, Supplies & Distribution
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2015Q1/2015Q4/2014Q3/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedNov 30, 201411/30/2014Aug 31, 201408/31/2014May 31, 201405/31/2014Feb 28, 201402/28/2014
Revenue68686762
Total other revenue--------
Total revenue68686762
Gross profit34343231
Total cost of revenue34343531
Total operating expense56545652
Selling / general / administrative19181918
Research & development2222
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income13131110
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax12141110
Income after tax8987
Income tax, total5544
Net income8987
Total adjustments to net income--------
Net income before extra. items8987
Minority interest0000
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items8987
Inc. avail. to common incl. extra. items8987
Diluted net income8987
Dilution adjustment--------
Diluted weighted average shares37373837
Diluted EPS excluding extraordinary itemsvalue per share0.210.240.200.18
Dividends per sharevalue per share--0.000.000.00
Diluted normalized EPSvalue per share0.210.240.200.18